U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 166

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
Bartter disease type 1Pathogenic
(Jul 12, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr15:48548031
GRCh38:
Chr15:48255834
SLC12A1Q656*Bartter disease type 1Pathogenic
(Sep 2, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr15:48541844
GRCh38:
Chr15:48249647
SLC12A1C586YBartter disease type 1Uncertain significance
(Feb 23, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr15:48539583
GRCh38:
Chr15:48247386
SLC12A1G537ABartter disease type 1Uncertain significance
(Feb 23, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr15:48536956
GRCh38:
Chr15:48244759
SLC12A1C436YBartter disease type 1Uncertain significance
(Feb 23, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr15:48551420
GRCh38:
Chr15:48259223
SLC12A1G689EBartter disease type 1Uncertain significance
(Feb 6, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr15:48591379
GRCh38:
Chr15:48299182
SLC12A1H1001QBartter disease type 1Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr15:48539164
GRCh38:
Chr15:48246967
SLC12A1T504IBartter disease type 1Uncertain significance
(Oct 19, 2020)
criteria provided, single submitter
9.
GRCh37:
Chr15:48513160
GRCh38:
Chr15:48220963
CTXN2-AS1, SLC12A1R199Gnot provided, Bartter disease type 1Conflicting interpretations of pathogenicity
(Jan 17, 2022)
criteria provided, conflicting interpretations
10.
GRCh37:
Chr15:48513137
GRCh38:
Chr15:48220940
CTXN2-AS1, SLC12A1I191NBartter disease type 1Likely pathogenic
(Dec 12, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr15:48539625
GRCh38:
Chr15:48247428
SLC12A1T551IBartter disease type 1Uncertain significance
(May 22, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr15:48539626
GRCh38:
Chr15:48247429
SLC12A1not provided, Bartter disease type 1Likely benign
(Jul 21, 2021)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr15:48551449
GRCh38:
Chr15:48259252
SLC12A1D699Nnot provided, Bartter disease type 1Benign/Likely benign
(Jun 4, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr15:48541891
GRCh38:
Chr15:48249694
SLC12A1not provided, Bartter disease type 1Likely benign
(Dec 28, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr15:48559809
GRCh38:
Chr15:48267612
SLC12A1Q736KBartter disease type 1, not providedUncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr15:48584054
GRCh38:
Chr15:48291857
SLC12A1K985Enot provided, Bartter disease type 1Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr15:48500310
GRCh38:
Chr15:48208113
CTXN2-AS1, SLC12A1L132FBartter disease type 1, not providedUncertain significance
(Feb 16, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr15:48591429
GRCh38:
Chr15:48299232
SLC12A1P1018Lnot provided, Bartter disease type 1Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr15:48580264
GRCh38:
Chr15:48288067
SLC12A1S885LBartter disease type 1, not providedUncertain significance
(Apr 28, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr15:48537081
GRCh38:
Chr15:48244884
SLC12A1G478Rnot provided, Bartter disease type 1Conflicting interpretations of pathogenicity
(Sep 2, 2022)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr15:48527089
GRCh38:
Chr15:48234892
SLC12A1E368Gnot provided, Bartter disease type 1Conflicting interpretations of pathogenicity
(May 4, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr15:48577324
GRCh38:
Chr15:48285127
SLC12A1Q836Lnot provided, Bartter disease type 1Uncertain significance
(Mar 7, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr15:48500034
GRCh38:
Chr15:48207837
CTXN2-AS1, SLC12A1T40Anot provided, Bartter disease type 1Uncertain significance
(Jul 13, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr15:48580692
GRCh38:
Chr15:48288495
SLC12A1R951HBartter disease type 1, not providedUncertain significance
(Feb 3, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr15:48595038
GRCh38:
Chr15:48302841
SLC12A1L1086IBartter disease type 1, not providedUncertain significance
(May 25, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr15:48536965
GRCh38:
Chr15:48244768
SLC12A1R439Qnot provided, Bartter disease type 1Pathogenic/Likely pathogenic
(Jun 23, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr15:48500139
GRCh38:
Chr15:48207942
CTXN2-AS1, SLC12A1Q75*not provided, Bartter disease type 1Pathogenic
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr15:48543952
GRCh38:
Chr15:48251755
LOC126862123, SLC12A1T643fsBartter disease type 1Likely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr15:48548109
GRCh38:
Chr15:48255912
SLC12A1Bartter disease type 1Pathogenic
(Oct 5, 2019)
criteria provided, single submitter
30.
GRCh37:
Chr15:48500298
GRCh38:
Chr15:48208101
CTXN2-AS1, SLC12A1R128*not provided, Bartter disease type 1Pathogenic
(Mar 3, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr15:48539652
GRCh38:
Chr15:48247455
SLC12A1L560PBartter disease type 1Likely pathogenic
(Oct 2, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr15:48580638-48580639
GRCh38:
Chr15:48288441-48288442
SLC12A1W936fsBartter disease type 1Likely pathogenic
(Sep 15, 2020)
criteria provided, single submitter
33.
GRCh37:
Chr15:48580263
GRCh38:
Chr15:48288066
SLC12A1S885PBartter disease type 1Uncertain significance
(Feb 11, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr15:48561834
GRCh38:
Chr15:48269637
SLC12A1not provided, Bartter disease type 1Benign
(Jul 15, 2021)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr15:48559826
GRCh38:
Chr15:48267629
SLC12A1not provided, Bartter disease type 1Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr15:48593580
GRCh38:
Chr15:48301383
SLC12A1not provided, Bartter disease type 1Pathogenic/Likely pathogenic
(May 8, 2023)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr15:48537004
GRCh38:
Chr15:48244807
SLC12A1G452ABartter disease type 1, not providedUncertain significance
(Dec 16, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr15:48559885
GRCh38:
Chr15:48267688
SLC12A1R761QBartter disease type 1Uncertain significance
(Sep 27, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr15:48543859
GRCh38:
Chr15:48251662
LOC126862123, SLC12A1G612RBartter disease type 1Likely pathogenic
(Sep 27, 2019)
criteria provided, single submitter
40.
GRCh37:
Chr15:48533801
GRCh38:
Chr15:48241604
SLC12A1Bartter disease type 1Uncertain significance
(Jul 27, 2019)
criteria provided, single submitter
41.
GRCh37:
Chr15:48548046
GRCh38:
Chr15:48255849
SLC12A1V661Mnot provided, Bartter disease type 1Uncertain significance
(Apr 12, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr15:48512923
GRCh38:
Chr15:48220726
SLC12A1Q171HInborn genetic diseases, not provided, Bartter disease type 1
Uncertain significance
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr15:48543854-48543855
GRCh38:
Chr15:48251657-48251658
LOC126862123, SLC12A1F611fsBartter disease type 1Uncertain significance
(Sep 27, 2017)
criteria provided, single submitter
44.
GRCh37:
Chr15:48577390
GRCh38:
Chr15:48285193
SLC12A1R858Lnot provided, Bartter disease type 1Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr15:48561901
GRCh38:
Chr15:48269704
SLC12A1Y781Cnot provided, Bartter disease type 1Uncertain significance
(Jun 4, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr15:48539121
GRCh38:
Chr15:48246924
SLC12A1S490ABartter disease type 1Uncertain significance
(Oct 12, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr15:48527103
GRCh38:
Chr15:48234906
SLC12A1R373CBartter disease type 1Uncertain significance
(Mar 11, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr15:48521468
GRCh38:
Chr15:48229271
SLC12A1not provided, Bartter disease type 1Conflicting interpretations of pathogenicity
(Dec 18, 2021)
criteria provided, conflicting interpretations
49.
GRCh37:
Chr15:48521421
GRCh38:
Chr15:48229224
SLC12A1P254Anot provided, Bartter disease type 1Uncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr15:48518783
GRCh38:
Chr15:48226586
SLC12A1Bartter disease type 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr15:48518760
GRCh38:
Chr15:48226563
SLC12A1V239ABartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
52.
GRCh37:
Chr15:48595298
GRCh38:
Chr15:48303101
SLC12A1Bartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr15:48577363
GRCh38:
Chr15:48285166
SLC12A1E849GBartter disease type 1Uncertain significance
(Mar 9, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr15:48577345
GRCh38:
Chr15:48285148
SLC12A1A843VBartter disease type 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr15:48566833
GRCh38:
Chr15:48274636
SLC12A1Q823PBartter disease type 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr15:48566770
GRCh38:
Chr15:48274573
SLC12A1D802Gnot provided, Bartter disease type 1, Inborn genetic diseases
Uncertain significance
(Apr 9, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr15:48559875
GRCh38:
Chr15:48267678
SLC12A1D758HBartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr15:48595122
GRCh38:
Chr15:48302925
SLC12A1Bartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr15:48594988
GRCh38:
Chr15:48302791
SLC12A1L1069WBartter disease type 1Uncertain significance
(Jul 19, 2021)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr15:48594942
GRCh38:
Chr15:48302745
SLC12A1Bartter disease type 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr15:48559812
GRCh38:
Chr15:48267615
SLC12A1A737TBartter disease type 1, not provided, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Sep 26, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr15:48559798
GRCh38:
Chr15:48267601
SLC12A1M732KBartter disease type 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr15:48559748
GRCh38:
Chr15:48267551
SLC12A1Bartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr15:48512873
GRCh38:
Chr15:48220676
SLC12A1G155SBartter disease type 1, not providedUncertain significance
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr15:48512872
GRCh38:
Chr15:48220675
SLC12A1Bartter disease type 1, not providedConflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr15:48512844
GRCh38:
Chr15:48220647
SLC12A1T145NBartter disease type 1Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
67.
GRCh37:
Chr15:48593518
GRCh38:
Chr15:48301321
SLC12A1R1035SBartter disease type 1Uncertain significance
(Jan 15, 2018)
criteria provided, single submitter
68.
GRCh37:
Chr15:48584020
GRCh38:
Chr15:48291823
SLC12A1I973MBartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr15:48543928
GRCh38:
Chr15:48251731
LOC126862123, SLC12A1E635KBartter disease type 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
70.
GRCh37:
Chr15:48499975
GRCh38:
Chr15:48207778
SLC12A1R20HBartter disease type 1, not providedConflicting interpretations of pathogenicity
(Jun 18, 2022)
criteria provided, conflicting interpretations
71.
GRCh37:
Chr15:48499849
GRCh38:
Chr15:48207652
SLC12A1Bartter disease type 1Likely benign
(Jan 12, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr15:48596124
GRCh38:
Chr15:48303927
SLC12A1Bartter disease type 1Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
73.
GRCh37:
Chr15:48595944
GRCh38:
Chr15:48303747
SLC12A1Bartter disease type 1Likely benign
(Jan 13, 2018)
criteria provided, single submitter
74.
GRCh37:
Chr15:48595711
GRCh38:
Chr15:48303514
SLC12A1Bartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr15:48595675
GRCh38:
Chr15:48303478
SLC12A1Bartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
76.
GRCh37:
Chr15:48595578
GRCh38:
Chr15:48303381
SLC12A1Bartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr15:48595518
GRCh38:
Chr15:48303321
SLC12A1Bartter disease type 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
78.
GRCh37:
Chr15:48580665
GRCh38:
Chr15:48288468
SLC12A1R942TInborn genetic diseases, Bartter disease type 1Uncertain significance
(Dec 16, 2021)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr15:48580625
GRCh38:
Chr15:48288428
SLC12A1I929VBartter disease type 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr15:48580286
GRCh38:
Chr15:48288089
SLC12A1Bartter disease type 1Uncertain significance
(Mar 16, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr15:48541773
GRCh38:
Chr15:48249576
SLC12A1not provided, Bartter disease type 1Uncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr15:48539189
GRCh38:
Chr15:48246992
SLC12A1not provided, Bartter disease type 1Conflicting interpretations of pathogenicity
(May 8, 2021)
criteria provided, conflicting interpretations
83.
GRCh37:
Chr15:48539147
GRCh38:
Chr15:48246950
SLC12A1Bartter disease type 1Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
84.
GRCh37:
Chr15:48533808
GRCh38:
Chr15:48241611
SLC12A1not provided, Bartter disease type 1Benign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr15:48533699
GRCh38:
Chr15:48241502
SLC12A1not provided, Bartter disease type 1Benign/Likely benign
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr15:48559841
GRCh38:
Chr15:48267644
SLC12A1Y748fsnot provided, Bartter disease type 1Pathogenic
(Sep 2, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr15:48521477
GRCh38:
Chr15:48229280
CTXN2-AS1, SLC12A1not provided, Bartter disease type 1Likely benign
(Aug 17, 2021)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr15:48500331
GRCh38:
Chr15:48208134
SLC12A1A139Tnot provided, Bartter disease type 1Benign
(Aug 4, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr15:48518739
GRCh38:
Chr15:48226542
SLC12A1A232VBartter disease type 1, not providedBenign/Likely benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr15:48500105
GRCh38:
Chr15:48207908
CTXN2-AS1, SLC12A1Bartter disease type 1, not providedBenign/Likely benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr15:48551421
GRCh38:
Chr15:48259224
SLC12A1not provided, Bartter disease type 1Benign/Likely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr15:48559884
GRCh38:
Chr15:48267687
SLC12A1not provided, Bartter disease type 1Likely benign
(Nov 19, 2021)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr15:48591430
GRCh38:
Chr15:48299233
SLC12A1Bartter disease type 1, not providedConflicting interpretations of pathogenicity
(Sep 29, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr15:48539526
GRCh38:
Chr15:48247329
SLC12A1Bartter disease type 1, not providedLikely benign
(Jun 26, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr15:48527147
GRCh38:
Chr15:48234950
SLC12A1not provided, Bartter disease type 1Conflicting interpretations of pathogenicity
(Feb 7, 2018)
criteria provided, conflicting interpretations
96.
GRCh37:
Chr15:48559763
GRCh38:
Chr15:48267566
SLC12A1not provided, Bartter disease type 1Benign/Likely benign
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr15:48580672-48580723
GRCh38:
Chr15:48288475-48288526
SLC12A1Bartter disease type 1Likely pathogenic
(Apr 2, 2018)
criteria provided, single submitter
98.
GRCh37:
Chr15:48566800
GRCh38:
Chr15:48274603
SLC12A1I812Rnot provided, Bartter disease type 1Uncertain significance
(Oct 31, 2018)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr15:48500122
GRCh38:
Chr15:48207925
CTXN2-AS1, SLC12A1C69Ynot provided, Bartter disease type 1Uncertain significance
(Oct 31, 2018)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr15:48519315
GRCh38:
Chr15:48227118
CTXN2-AS1, SLC12A1T223MBartter disease type 1Uncertain significance
(May 3, 2020)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination